Procter & Gamble CapEx increased by 20.5% to $1.20B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 20.8%, from $993.00M to $1.20B. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 7.9% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $714.00M | $1.09B | $507.00M | $866.00M | $692.00M | $890.00M | $852.00M | $586.00M | $734.00M | $925.00M | $993.00M | $621.00M | $783.00M | $993.00M | $1.37B | $410.00M | $996.00M | $1.20B |
| QoQ Change | — | +52.8% | -53.5% | +70.8% | -20.1% | +28.6% | -4.3% | -31.2% | +25.3% | +26.0% | +7.4% | -37.5% | +26.1% | +26.8% | +38.4% | -70.2% | +142.9% | +20.5% |
| YoY Change | — | — | — | — | -3.1% | -18.4% | +68.0% | -32.3% | +6.1% | +3.9% | +16.5% | +6.0% | +6.7% | +7.4% | +38.4% | -34.0% | +27.2% | +20.8% |
| Segment | FY'21 | FY'22 |
|---|---|---|
| Fabric Care And Home Care | $1.01B | $988.00M |
| Baby Feminineand Family Care | $814.00M | $932.00M |
| Health Care | $364.00M | $410.00M |
| Beauty | $386.00M | $331.00M |
| Grooming | $291.00M | $260.00M |
| Corporate | -$74.00M | $235.00M |
| Total | $2.79B | $3.16B |
All segment values are derived from annual filings.
Baby Feminineand Family Care, Beauty, Corporate, Fabric Care And Home Care, Grooming, Health Care were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.